Some Existence Results for a Kirchhoff Type Logarithmic Problem in Bounded Domains
Journal of Partial Differential Equations · 30.10.2026 · 39 (3) · 271-294
DOI: 10.4208/jpde.v39.n3.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Partial Differential Equations, online erschienen am 30.10.2026. Verfasst von Yongbin Wang und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The main feature of this paper lies in the fact that it is the first attempt to study the existence about the Kirchhoff type problem involving both logarithmic and critical nonlinearities in bounded domains. Since the logarithmic nonlinearity may change sign in the domain and does not satisfy the Ambrosetti-Rabinowitz condition, we cannot obtain the boundedness of \((PS)\) sequence in a standard way. Moreover, the lack of compactness makes our problem become much complex due to the critical nonlinearity. By introducing some truncation techniques and the Nehari manifold method, we overcome these obstacles and obtain the existence of positive solutions for \(N=3\) and \(N\geq 4\) respectively.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, Y., & Fan, H. (2026). Some Existence Results for a Kirchhoff Type Logarithmic Problem in Bounded Domains. Journal of Partial Differential Equations, 39(3), 271-294. https://doi.org/10.4208/jpde.v39.n3.2
Vancouver
Wang Y, Fan H. Some Existence Results for a Kirchhoff Type Logarithmic Problem in Bounded Domains. Journal of Partial Differential Equations. 2026;39(3):271-294. doi:10.4208/jpde.v39.n3.2
BibTeX
@article{Wang2026,
author = {Wang, Yongbin and Fan, Haining},
title = {Some Existence Results for a Kirchhoff Type Logarithmic Problem in Bounded Domains},
journal = {Journal of Partial Differential Equations},
year = {2026},
volume = {39},
number = {3},
pages = {271--294},
doi = {10.4208/jpde.v39.n3.2}
}
EUVIMED